» Articles » PMID: 27231010

Essential Role of MiRNAs in Orchestrating the Biology of the Tumor Microenvironment

Overview
Journal Mol Cancer
Publisher Biomed Central
Date 2016 May 28
PMID 27231010
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are emerging as central players in shaping the biology of the Tumor Microenvironment (TME). They do so both by modulating their expression levels within the different cells of the TME and by being shuttled among different cell populations within exosomes and other extracellular vesicles. This review focuses on the state-of-the-art knowledge of the role of miRNAs in the complexity of the TME and highlights limitations and challenges in the field. A better understanding of the mechanisms of action of these fascinating micro molecules will lead to the development of new therapeutic weapons and most importantly, to an improvement in the clinical outcome of cancer patients.

Citing Articles

Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles in Disease Therapy.

Zhao W, Li K, Li L, Wang R, Lei Y, Yang H Int J Mol Sci. 2024; 25(14).

PMID: 39062956 PMC: 11277139. DOI: 10.3390/ijms25147715.


MicroRNA-mediated metabolic regulation of immune cells in cancer: an updated review.

Khameneh S, Razi S, Lashanizadegan R, Akbari S, Sayaf M, Haghani K Front Immunol. 2024; 15:1424909.

PMID: 39007129 PMC: 11239499. DOI: 10.3389/fimmu.2024.1424909.


Growth Inhibition of Retinoblastoma Cell Line by Exosome-Mediated Transfer of miR-142-3p.

Plousiou M, De Vita A, Miserocchi G, Bandini E, Vannini I, Melloni M Cancer Manag Res. 2022; 14:2119-2131.

PMID: 35791342 PMC: 9250773. DOI: 10.2147/CMAR.S351979.


Research progress and clinical application prospects of miRNAs in oral cancer.

Xing L, Feng Z, Nie H, Liu M, Liu Y, Zhang X Mol Biol Rep. 2022; 49(11):10653-10665.

PMID: 35725854 DOI: 10.1007/s11033-022-07604-w.


Circulating MicroRNAs in Gastrointestinal Cancer.

Ohtsuka M, Iwamoto K, Naito A, Imasato M, Hyuga S, Nakahara Y Cancers (Basel). 2021; 13(13).

PMID: 34283058 PMC: 8267753. DOI: 10.3390/cancers13133348.


References
1.
He T, Qi F, Jia L, Wang S, Song N, Guo L . MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2. J Pathol. 2014; 232(5):499-508. DOI: 10.1002/path.4324. View

2.
Colvin E . Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Front Oncol. 2014; 4:137. PMC: 4047518. DOI: 10.3389/fonc.2014.00137. View

3.
Gao J, Zhang Q, Xu J, Guo L, Li X . Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA. Chin J Cancer Res. 2014; 25(6):743-8. PMC: 3872537. DOI: 10.3978/j.issn.1000-9604.2013.12.04. View

4.
Yamada N, Tsujimura N, Kumazaki M, Shinohara H, Taniguchi K, Nakagawa Y . Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells. Biochim Biophys Acta. 2014; 1839(11):1256-72. DOI: 10.1016/j.bbagrm.2014.09.002. View

5.
Yin Y, Cai X, Chen X, Liang H, Zhang Y, Li J . Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth. Cell Res. 2014; 24(10):1164-80. PMC: 4185347. DOI: 10.1038/cr.2014.121. View